In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model - Thiemann, Markus; Oertel, Susanne; Ehemann, Volker; Weichert, Wilko; Stenzinger, Albrecht; Bischof, Marc; Weber, Klaus-Josef; Lopez Perez, Ramon; Haberkorn, Uwe; Kulozik, Andreas; Debus, Jürgen; Huber, Peter E.; et al. (Radiation oncology, 2012)
Gesehen am 19.04.2018